TYLENOL SINUS SEVERE
NDC 70264-026, ACETAMINOPHEN, tablet, coated, from R J General Corporation.
- Product NDC
- 70264-026
- Status
- Listed
- Labeler
- R J General Corporation
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70264-026 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ACETAMINOPHEN325 mg/1
- GUAIFENESIN200 mg/1
- PHENYLEPHRINE HYDROCHLORIDE5 mg/1
Pharmacologic classes
Adrenergic alpha1-Agonists [MoA]; Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; alpha-1 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70264-026-02 | 70264002602 | 50 POUCH in 1 BOX (70264-026-02) / 2 TABLET, COATED in 1 POUCH |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 70264-026 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70264-026 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70264-026. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.